Literature DB >> 18158061

Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.

Jennifer Yates1, Barry Stein.   

Abstract

Intravesical Bacillus Calmette-Guerin (BCG) is usually a well-tolerated treatment strategy for transitional cell cancer of the bladder. We report a patient with penile and bladder mucosal lesions with inguinal adenopathy after six instillations of intravesical BCG. Pathology demonstrated inflammation with granulomatous changes. The lesions and adenopathy resolved with antituberculous drug treatment. We describe the patient's clinical presentation and review the complications of intravesical BCG treatment.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18158061     DOI： 10.1016/j.urology.2007.09.044

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  2 in total

Review 1.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

2.  Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy.

Authors:  Guven Aslan; Can Sevinc; Burcin Tuna; Sermin Ozkal; Kutsal Yorukoglu
Journal:  Indian J Urol       Date:  2013-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.